Trial Profile
Effects of toremifene and letrozole on serum lipids and bone metabolism in post-menopausal patients with estrogen receptor-positive breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Apr 2014
Price :
$35
*
At a glance
- Drugs Toremifene (Primary) ; Letrozole
- Indications Breast cancer
- Focus Pharmacodynamics
- 15 Apr 2014 New trial record
- 21 Mar 2014 Results presented at the 9th European Breast Cancer Conference.